Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts

被引:101
作者
Yang, Xi-Ming
Philipp, Sebastian
Downey, James M.
Cohen, Michael V.
机构
[1] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA
[2] Univ S Alabama, Coll Med, Dept Med, Mobile, AL 36688 USA
关键词
atrial natriuretic peptide; guanylyl cyclase; ischemia/reperfusion; mK(ATP) channels; protein kinase G;
D O I
10.1007/s00395-006-0587-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion reduces infarction in rabbit hearts and whether protection is related to activation of protein kinase G (PKG). Isolated rabbit hearts were subjected to a 30-min period of regional ischemia; treated hearts received a 20-min infusion of ANP (0.1 mu M) starting 5 min before 2 h of reperfusion. ANP infusion decreased infarction from 31.5 +/- 2.4% of the risk zone in untreated hearts to 12.5 +/- 2.0% (P < 0.001). To explore mechanisms of protection ischemic hearts were treated simultaneously with ANP and isatin, a blocker of the natriuretic peptide receptor, shortly before reperfusion. ANP's protective effect was aborted (36.8 +/- 2.9% infarction). There is no acceptable blocker of protein kinase G that can be used in intact organs. However, 8-(4-chlorophenylthio)-guanosine 3', 5'-cyclic monophosphate (10 mu M), a cell-permeable cGMP analog that directly activates PKG, was infused from 5 min before to 15 min after reperfusion. The PKG activator mimicked ANP's protection with only 18.2 +/- 3.6% infarction (P < 0.001). 5-Hydroxyde-canoate (5-HD), a putative mitochondrial K-ATP channel (mK(ATP)) inhibitor, abrogated ANP's protection (34.4 +/- 2.6% infarction). Unexpectedly, 1H-[1,2,4]oxadiazole- [4,3-a]quinoxalin-1-one (ODQ), a blocker of soluble guanylyl cyclase also prevented ANP's infarct-sparing effect. It is unclear whether this observation implicated participation of soluble guanylyl cyclase in the mechanism or simply a lack of selectivity of ODQ. Finally the reperfusion injury salvage kinases (RISK), phosphatidylinositol 3-kinase and extracellular signal-regulated kinase, were implicated in ANP's mechanism since either wortmannin or PD98059 infused at reperfusion prevented ANP's infarct-sparing effect. ANP administered just prior to reperfusion protects hearts against infarction, likely by activation of PKG, opening of mK(ATP), and stimulation of downstream kinases.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 64 条
[1]   Vascular actions of natriuretic peptides - Cyclic GMP-dependent and -independent mechanisms [J].
Ahluwalia, A ;
MacAllister, RJ ;
Hobbs, AJ .
BASIC RESEARCH IN CARDIOLOGY, 2004, 99 (02) :83-89
[2]   Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction [J].
Airhart, N ;
Yang, YF ;
Roberts, CT ;
Silberbach, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38693-38698
[3]   Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells [J].
Aizawa, T ;
Wei, H ;
Miano, JM ;
Abe, J ;
Berk, BC ;
Yan, C .
CIRCULATION RESEARCH, 2003, 93 (05) :406-413
[4]   The natriuretic peptides - An introduction [J].
Baxter, GF .
BASIC RESEARCH IN CARDIOLOGY, 2004, 99 (02) :71-75
[5]   Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK [J].
Baxter, GF ;
Mocanu, MM ;
Brar, BK ;
Latchman, DS ;
Yellon, DM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (06) :930-939
[6]  
BAXTER GF, 2000, CIRCULATION, V102, P2
[7]   Il2 transcription -: division not required [J].
Bell, E .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :185-185
[8]   Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review [J].
Clerico, A ;
Emdin, M .
CLINICAL CHEMISTRY, 2004, 50 (01) :33-50
[9]   Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial KATP channels [J].
Cohen, MV ;
Yang, XM ;
Liu, GS ;
Heusch, G ;
Downey, JM .
CIRCULATION RESEARCH, 2001, 89 (03) :273-278
[10]   Atrial natriuretic peptide influence on nitric oxide system in kidney and heart [J].
Costa, MD ;
Elesgaray, R ;
Loria, A ;
Balaszczuk, AM ;
Arranz, C .
REGULATORY PEPTIDES, 2004, 118 (03) :151-157